Should You Buy the Dip in These 2 Beaten-Down Artificial Intelligence (AI) Stocks?

CoreWeave and Broadcom both reported strong revenue growth, but each stock fell after earnings on disappointing guidance: CoreWeave’s revenue rose 111.6% to $2.1B but net loss widened to $740M, while Broadcom’s revenue increased 48% to $22.2B with AI chip sales up 143% to $10.8B. CoreWeave faces elevated risk from its 8.2 price-to-sales ratio and 67% revenue concentration in Microsoft, whereas Broadcom looks comparatively more attractive despite a forward P/E of 33 and concentrated customer exposure. The article argues Broadcom is the better dip-buy on durable AI demand, while CoreWeave warrants caution.

Analysis

The market is treating “AI” as one factor, but the earnings reactions suggest two very different businesses are being repriced. CoreWeave is a leveraged capacity-provider: upside is tied to utilization and customer concentration, while downside is dominated by financing risk and any pause in hyperscaler capex. That makes it a high-beta claim on the durability of AI spend, not a clean operating business; if Microsoft moderates orders, the equity can de-rate much faster than revenue growth would imply.

Broadcom is the more interesting second-order winner because it sits inside the supply chain transition from general-purpose GPU scarcity to custom silicon optimization. If hyperscalers keep pushing bespoke inference/training architectures to lower unit economics, AVGO can gain share even if Nvidia remains the default standard. The catch is that the market is no longer paying for “AI exposure” alone; it wants evidence of sustained acceleration, so any guide-down creates a valuation air pocket before fundamentals meaningfully break.

The contrarian read is that the post-earnings selloffs may be asymmetrical: CRWV looks like a balance-sheet/financing story disguised as growth, while AVGO looks like a high-quality compounder being marked down for a one-quarter expectation miss. In the next 1-3 months, the key catalyst is not absolute AI demand but whether hyperscalers re-affirm capex budgets into mid-year planning; that will determine whether these dips are tradeable or the start of a broader de-rating. Relative to the group, MSFT is the quiet beneficiary if it can keep extracting AI capacity without expanding customer concentration risk on its own books.

Key Decisions for Investors

• Prefer long AVGO on a 3-6 month horizon after the pullback; risk/reward is attractive if AI custom-chip demand remains >100% growth, with downside cushioned by cash flow and dividends.
• Avoid chasing CRWV size here; if initiating at all, keep it as a small optionality position only, since concentration and funding risk can produce 20-30% drawdowns on modest guidance disappointment.
• Pair trade: long AVGO / short CRWV for a cleaner expression of AI infrastructure demand with lower financing risk and better downside protection over the next 1-2 quarters.
• For a tactical hedge against AI capex wobble, consider short-dated downside protection on CRWV into the next hyperscaler capex commentary window; the name should react more violently to any spending softening than the larger platform vendors.
• Monitor MSFT for confirmation of spend durability; a renewed capex uptrend would support both AVGO and CRWV, but MSFT is the better quality way to stay long AI infrastructure without taking single-customer balance-sheet risk.